The Fungal Infections and Mycology section of IDWC 2026 will address the rising global burden of fungal diseases. The panel of experts will cover epidemiology, emergent fungal pathogens, and challenges in diagnosis and delays in treatment. Participants will have the opportunity to discuss antifungal therapies, management strategies, and other related matters. IDWC 2026 will raise awareness of the impact of fungal infections on healthcare systems. The use of clinical case studies will provide insight into the clinical aspects related to severe fungal infections.
The panel will discuss the developments and global implications of antifungal resistance, including emerging resistant strains and treatment failures. The program will encourage innovative research in antifungal drug development. The participants will discuss new diagnostic tools, laboratory techniques, and other resources, including new developments in molecular identification methods. The session will also discuss the challenges presented by fungal infections in immunocompromised individuals. These discussions will facilitate improvement in clinical outcomes through research development and advancement.
Furthermore, the session will also address policies and prevention strategies of interest to participants. Panelists will expose global efforts to control the impact of fungal infections. The program will provide a forum for researchers and healthcare providers to collaborate. Participants will engage in discussions focused on the importance of greater awareness and early detection. Infection control and prevention practices will be emphasized through the program. The program will conclude with discussions surrounding the direction of future mycology research and preparedness efforts for emerging fungal pathogens.